{"transactions":[{"id":721270,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":7861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":67941,"derivative":{"exercise_price":4.38,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":7861},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721269,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":4065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1/4th of the total award on October 26, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":26977,"derivative":{"exercise_price":4.3,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":4065},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721268,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1/4th of the total award on October 17, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":17016,"derivative":{"exercise_price":8.39,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721267,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":4290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total award on September 25, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":13299,"derivative":{"exercise_price":10.85,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":4290},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721266,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":14198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":75802,"derivative":{"exercise_price":4.38,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":14198},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721265,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":8958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1/4th of the total award on October 26, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":31042,"derivative":{"exercise_price":4.3,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":8958},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721264,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":7261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1/4th of the total award on October 17, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":21016,"derivative":{"exercise_price":8.39,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":7261},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721263,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":9301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1/4th of the total award on September 25, 2024, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":17589,"derivative":{"exercise_price":10.85,"expiration_date":"2033-09-26","underlying":"Common Stock","underlying_shares":9301},"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721262,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":20216,"price":25.1868,"value":509176.3488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.42 per share, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721261,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":7861,"price":4.38,"value":34431.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":20216,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721260,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":4065,"price":4.3,"value":17479.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":12355,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721259,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":8.39,"value":33560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":8290,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721258,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":4290,"price":10.85,"value":46546.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":4290,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721257,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":42350,"price":25.2084,"value":1067575.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721256,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":14198,"price":4.38,"value":62187.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":42350,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721255,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":8958,"price":4.3,"value":38519.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":28152,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721254,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":7261,"price":8.39,"value":60919.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":19194,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":721253,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:27:06.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":9301,"price":10.85,"value":100915.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":11933,"source":{"system":"sec-edgar","filing":"0001836297-26-000005","document":"form4-07012026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000005/form4-07012026_080701.xml","form_type":"4"}},{"id":893414,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T21:34:46.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":19.63,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001836297-26-000002","document":"form4-02192026_090243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000183629726000002/form4-02192026_090243.xml","form_type":"4"}},{"id":1215111,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:10:37.000Z","date":"2024-09-27","kind":"purchase","planned":false,"acquired":true,"shares":2632,"price":18,"value":47376.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering."}],"balance_after":2632,"source":{"system":"sec-edgar","filing":"0001415889-25-007505","document":"form4-03102025_080333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925007505/form4-03102025_080333.xml","form_type":"4"}},{"id":1255821,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T21:15:32.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":4.38,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-004854","document":"form4-02202025_090229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925004854/form4-02202025_090229.xml","form_type":"4"}},{"id":1324151,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-20T21:04:55.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":4.3,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-029962","document":"form4-12202024_091252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924029962/form4-12202024_091252.xml","form_type":"4"}},{"id":1860200,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2023-06-09T20:20:59.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":6060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":6060,"derivative":{"underlying":"Common Stock","underlying_shares":6060},"source":{"system":"sec-edgar","filing":"0001209191-23-035835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123035835/doc4.xml","form_type":"4"}},{"id":1860199,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2023-06-09T20:20:59.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":6060,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on June 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount includes 20 shares that were inadvertently omitted from the Form 4 filed on March 7, 2023 by the Reporting Person."}],"balance_after":27502,"source":{"system":"sec-edgar","filing":"0001209191-23-035835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123035835/doc4.xml","form_type":"4"}},{"id":1965246,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T22:04:51.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":12722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":25439,"derivative":{"underlying":"Common Stock","underlying_shares":12722},"source":{"system":"sec-edgar","filing":"0001209191-23-016824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123016824/doc4.xml","form_type":"4"}},{"id":1965245,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2023-03-07T22:04:51.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":12722,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on March 3, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":21422,"source":{"system":"sec-edgar","filing":"0001209191-23-016824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123016824/doc4.xml","form_type":"4"}},{"id":2047308,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2023-01-24T21:30:22.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":70000,"derivative":{"underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-23-004609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919123004609/doc4.xml","form_type":"4"}},{"id":2237383,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2022-06-09T20:26:15.000Z","date":"2022-06-07","kind":"exercise","acquired":false,"shares":6061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":12120,"derivative":{"underlying":"Common Stock","underlying_shares":6061},"source":{"system":"sec-edgar","filing":"0001209191-22-035391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122035391/doc4.xml","form_type":"4"}},{"id":2237382,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2022-06-09T20:26:15.000Z","date":"2022-06-07","kind":"exercise","acquired":true,"shares":6061,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the partial vesting and settlement of Restricted Stock Units (\"RSUs\") on June 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's Common Stock."}],"balance_after":8720,"source":{"system":"sec-edgar","filing":"0001209191-22-035391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122035391/doc4.xml","form_type":"4"}},{"id":2347310,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2022-03-07T21:22:09.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":38161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which each represent a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":38161,"derivative":{"underlying":"Common Stock","underlying_shares":38161},"source":{"system":"sec-edgar","filing":"0001209191-22-016641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122016641/doc4.xml","form_type":"4"}},{"id":2347309,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T21:22:09.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":60604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":60604,"derivative":{"exercise_price":4.08,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":60604},"source":{"system":"sec-edgar","filing":"0001209191-22-016641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122016641/doc4.xml","form_type":"4"}},{"id":2347308,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2022-03-07T21:22:09.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":761,"price":3.61,"value":2747.21,"ownership":{"direct":true},"balance_after":2659,"source":{"system":"sec-edgar","filing":"0001209191-22-016641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122016641/doc4.xml","form_type":"4"}},{"id":2347307,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2022-03-07T21:22:09.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":604,"price":10.68,"value":6450.72,"ownership":{"direct":true},"balance_after":1898,"source":{"system":"sec-edgar","filing":"0001209191-22-016641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122016641/doc4.xml","form_type":"4"}},{"id":2347306,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Common Stock","published_at":"2022-03-07T21:22:09.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":1294,"price":4.61,"value":5965.34,"ownership":{"direct":true},"balance_after":1294,"source":{"system":"sec-edgar","filing":"0001209191-22-016641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919122016641/doc4.xml","form_type":"4"}},{"id":2675256,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Restricted Stock Units","published_at":"2021-06-09T22:35:35.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":18181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which each represent a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."}],"balance_after":18181,"derivative":{"underlying":"Common Stock","underlying_shares":18181},"source":{"system":"sec-edgar","filing":"0001209191-21-039276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121039276/doc4.xml","form_type":"4"}},{"id":2675255,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":34002,"kind":"person","name":"Barton Shane","position":1,"cik":"0001836297","reported_name":"Barton Shane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Corporate Controller"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-09T22:35:35.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":31242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date."}],"balance_after":31242,"derivative":{"exercise_price":11.34,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":31242},"source":{"system":"sec-edgar","filing":"0001209191-21-039276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121039276/doc4.xml","form_type":"4"}}]}